Gwen A Fyfe Net Worth & Insider Trades
Gwen A Fyfe - Director, Cascadian Therapeutics, Inc
What is Gwen A Fyfe's Net Worth?
The current estimated net worth of Cascadian Therapeutics, Inc's Director, Gwen A Fyfe, is estimated to be about $85.9K . Gwen A Fyfe owns about 3,332 units of Cascadian Therapeutics, Inc common stock. In the last year at Cascadian Therapeutics, Inc, Gwen A Fyfe has sold an estimated value of $8.56K worth.
What is Gwen A Fyfe's Past Insider Trading?
Gwen A Fyfe's largest purchase order was 1,666 units , worth over $6.86K on March 30, 2017. In total, Gwen A Fyfe has made about 4 transactions over a year of their time at Cascadian Therapeutics, Inc. Gwen A Fyfe usually trades in June, with the busiest year in 2017.
Gwen Fyfe
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Gwen A Fyfe's' Mailing Address?
- Mailing address is C/o Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 CO
What are Cascadian Therapeutics, Inc's Past Insider Trades?
Cascadian Therapeutics, Inc's most recent insider trade came on August 14, 2017 by Scott D. Myers who bought 5,500 units worth $20.54K . In the last year, insiders at Cascadian Therapeutics, Inc have sold an estimated value of $91.2K and bought an estimated value of $60.43M worth of shares. Insider trading is most common in March, with the busiest year in 2018. The most active traders at the company are Dunseth Scott Myers, President and CEO, Christopher Henney, Director, and Steven James, Director .
Cascadian Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||